CoChat

The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease

Open access
Zeitlow, Kahli, Charlambous, Lefko, Ng, Isaac, Gagrani, Sonal, Mihovilovic, Mirta, Luo, Shuhong, Rock, Daniel L., Saunders, Ann, Roses, Allen D., Gottschalk, W. Kirby · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Cited by 54

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

A variable-length poly-T variant in intron 6 of the TOMM40 gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's disease. In Caucasians, the three predominant alleles at this locus are Short (S), Long (L) or Very long (VL). On an APOE ε3/3 background, the S/VL and VL/VL genotypes are more protective than S/S. The '523 poly-T has regulatory properties, in that the VL poly-T results in higher expression than the S poly-T in luciferase expression systems. The aim of the current work was to identify effects on cellular bioenergetics of increased TOM40 protein expression. MitoTracker Green fluorescence and autophagic vesicle staining was the same in control and over-expressing cells, but TOM40 over-expression was associated with increased expression of TOM20, a preprotein receptor of the TOM complex, the mitochondrial chaperone HSPA9, and PDHE1a, and increased activities of the oxidative phosphorylation complexes I and IV and of the TCA member α-ketoglutaric acid dehydrogenase. Consistent with the complex I findings, respiration was more sensitive to inhibition by rotenone in control cells than in the TOM40 over-expressing cells. In the absence of inhibitors, total cellular ATP, the mitochondrial membrane potential, and respiration were elevated in the over-expressing cells. Spare respiratory capacity was greater in the TOM40 over-expressing cells than in the controls. TOM40 over-expression blocked Ab-elicited decreases in the mitochondrial membrane potential, cellular ATP levels, and cellular viability in the control cells. These data suggest elevated expression of TOM40 may be protective of mitochondrial function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2017.07.031

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 80

  1. Swerdlow, 2012, Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease, Antioxid. Redox Signal., 16, 1434, 10.1089/ars.2011.4149 · DOI · Paper page
  2. Perkins, 2016, Altered energy metabolism pathways in the posterior cingulate in young adult apolipoprotein E varepsilon4 carriers, J. Alzheimers. Dis., 53, 95, 10.3233/JAD-151205 · DOI · Paper page
  3. Du, 2010, Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model, Proc. Natl. Acad. Sci., 107, 18670, 10.1073/pnas.1006586107 · DOI · Paper page
  4. Manczak, 2004, Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease, NeuroMolecular Med., 5, 147, 10.1385/NMM:5:2:147 · DOI · Paper page
  5. Hayden, 2010, Occupational exposure to pesticides increases the risk of incident AD: the Cache County study, Neurology, 74, 1524, 10.1212/WNL.0b013e3181dd4423 · DOI · Paper page
  6. Richardson, 2014, Elevated serum pesticide levels and risk for Alzheimer disease, JAMA Neurol., 71, 284, 10.1001/jamaneurol.2013.6030 · DOI · Paper page
  7. Moreno, 1991, Mitochondrial bioenergetics as affected by DDT, Biochim. Biophys. Acta Bioenerg., 1060, 166, 10.1016/S0005-2728(09)91004-0 · DOI
  8. Casley, 2002, β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities, J. Neurochem., 80, 91, 10.1046/j.0022-3042.2001.00681.x · DOI · Paper page
  9. Casley, 2002, β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons, Neurobiol. Dis., 10, 258, 10.1006/nbdi.2002.0516 · DOI · Paper page
  10. Chacinska, 2009, Importing mitochondrial proteins: machineries and mechanisms, Cell, 138, 628, 10.1016/j.cell.2009.08.005 · DOI · Paper page
  11. Anandatheerthavarada, 2007, Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease, Rev. Neurosci., 18, 343, 10.1515/revneuro.2007.18.5.343 · DOI · Paper page
  12. Cenini, 2016, Amyloid β-peptides interfere with mitochondrial preprotein import competence by a coaggregation process, Mol. Biol. Cell, 27, 3257, 10.1091/mbc.E16-05-0313 · DOI · Paper page
  13. Schaefer, 2016, Metabolic characterization of intact cells reveals intracellular amyloid Beta but not its precursor protein to reduce mitochondrial respiration, PLoS One, 11, 10.1371/journal.pone.0168157 · DOI · Paper page
  14. Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 · DOI · Paper page
  15. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 10.1126/science.8346443 · DOI · Paper page
  16. Roses, 2010, A TOMM40 variable length polymorphism predicts the age of late-onset Alzheimer's disease, Pharmacogenomics J., 10, 375, 10.1038/tpj.2009.69 · DOI · Paper page
  17. Lutz, 2010, Genetic variation as a single locus and age of onset for Alzheimer's disease, Alzheimers Dement., 6, 125, 10.1016/j.jalz.2010.01.011 · DOI · Paper page
  18. Caselli, 2010, TOMM40, APOE and age of onset of Alzheimer's disease, Alzheimers Dement., 6, S202, 10.1016/j.jalz.2010.05.644 · DOI
  19. Hayden, 2012, A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging, Alzheimers Dement., 8, 381, 10.1016/j.jalz.2011.10.005 · DOI · Paper page
  20. Greenbaum, 2014, The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes, Eur. Neuropsychopharmacol., 24, 1492, 10.1016/j.euroneuro.2014.06.002 · DOI
  21. Laczó, 2015, The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment, Neurobiol. Aging, 36, 2024, 10.1016/j.neurobiolaging.2015.03.004 · DOI
  22. Payton, 2016, A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging, Neurobiol. Aging, 39, 217.e211, 10.1016/j.neurobiolaging.2015.11.017 · DOI
  23. Linnertz, 2014, The cis‑regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes, Alzheimers Dement., 10, 541, 10.1016/j.jalz.2013.08.280 · DOI · Paper page
  24. Bekris, 2012, Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE, J. Hum. Genet., 57, 18, 10.1038/jhg.2011.123 · DOI · Paper page
  25. Hedskog, 2012, Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene, J. Alzheimers Dis., 31, 527, 10.3233/JAD-2012-120580 · DOI
  26. Baker, 1990, A yeast mitochondrial outer membrane protein essential for protein import and cell viability, Nature, 348, 605, 10.1038/348605a0 · DOI · Paper page
  27. Taylor, 2003, Characterization of Neurospora crassa Tom40-deficient mutants and effect of specific mutations on Tom40 assembly, J. Biol. Chem., 278, 765, 10.1074/jbc.M208083200 · DOI
  28. Rossignol, 2004, Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells, Cancer Res., 64, 985, 10.1158/0008-5472.CAN-03-1101 · DOI · Paper page
  29. Smith, 1988, Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements, J. Biol. Chem., 263, 8300, 10.1016/S0021-9258(18)68477-7 · DOI · Paper page
  30. Linnertz, 2014, The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes, Alzheimers Dement., 10, 541, 10.1016/j.jalz.2013.08.280 · DOI · Paper page
  31. Taylor, 2013, A defined methodology for reliable quantification of Western blot data, Mol. Biotechnol., 55, 217, 10.1007/s12033-013-9672-6 · DOI · Paper page
  32. Taylor, 2014, The design of a quantitative western blot experiment, Biomed. Res. Int., 2014, 8, 10.1155/2014/361590 · DOI · Paper page
  33. Zinchuk, 2007, Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena, Acta Histochem. Cytochem., 40, 101, 10.1267/ahc.07002 · DOI · Paper page
  34. Hynes, 2006, The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity, Toxicol. in Vitro, 20, 785, 10.1016/j.tiv.2005.11.002 · DOI
  35. Lo, 1996, Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine: a phosphor with general application for measuring oxygen concentration in biological systems, Anal. Biochem., 236, 153, 10.1006/abio.1996.0144 · DOI · Paper page
  36. Hynes, 2006, Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes, Toxicol. Sci., 92, 186, 10.1093/toxsci/kfj208 · DOI · Paper page
  37. Rasmussen, 2003, Oxygen solubilities of media used in electrochemical respiration measurements, Anal. Biochem., 319, 105, 10.1016/S0003-2697(03)00274-4 · doi:10.1016/s0003-2697(03)00274-4
  38. Das, 1997, Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells, J. Exp. Med., 185, 1735, 10.1084/jem.185.10.1735 · DOI
  39. Coleman, 2010, A live-cell fluorescence microplate assay suitable for monitoring vacuolation arising from drug or toxic agent treatment, J. Biomol. Screen., 15, 398, 10.1177/1087057110364242 · DOI
  40. Kim, 2014, Abstract 2456: overexpression of TOM40 (translocase in the outer mitochondrial membrane 40) inhibits the cell proliferation, invasion and migration abilities in ovarian cancer cell lines, Cancer Res., 74, 2456, 10.1158/1538-7445.AM2014-2456 · doi:10.1158/1538-7445.am2014-2456
  41. Steinlechner-Maran, 1996, Oxygen dependence of respiration in coupled and uncoupled endothelial cells, Am. J. Phys., 271, C2053
  42. Brand, 2011, Assessing mitochondrial dysfunction in cells, Biochem. J., 435, 297, 10.1042/BJ20110162 · DOI · Paper page
  43. Wu, 1959, Regulatory mechanisms in carbohydrate metabolism. V. Limiting factors of glycolysis in HeLa cells, J. Biol. Chem., 234, 2806, 10.1016/S0021-9258(18)69674-7 · DOI · Paper page
  44. Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem. J., 417, 1, 10.1042/BJ20081386 · DOI · Paper page
  45. Fato, 2009, Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species, Biochim. Biophys. Acta Bioenerg., 1787, 384, 10.1016/j.bbabio.2008.11.003 · DOI · Paper page
  46. Caspersen, 2005, Mitochondrial A{beta}: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease, FASEB J., 19, 2040, 10.1096/fj.05-3735fje · DOI · Paper page
  47. Muirhead, 2010, The consequences of mitochondrial amyloid b-peptide in Alzheimer's disease, Biochem. J., 426, 255, 10.1042/BJ20091941 · DOI
  48. Chen, 2015, Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast, FEMS Yeast Res., 15, 10.1093/femsyr/fov061 · DOI
  49. Chen, 2010, Role of mitochondrial amyloid-β in Alzheimer's disease, J. Alzheimers Dis., 20, 569, 10.3233/JAD-2010-100357 · DOI · Paper page
  50. Keil, 2006, Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations, J. Alzheimers Dis., 9, 139, 10.3233/JAD-2006-9206 · DOI · Paper page
  51. Bobba, 2013, Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively, Mitochondrion, 13, 298, 10.1016/j.mito.2013.03.008 · DOI
  52. Takuma, 2005, ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction, FASEB J., 19, 597, 10.1096/fj.04-2582fje · DOI · Paper page
  53. Yoon, 2009, Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis, Exp. Mol. Med., 41, 611, 10.3858/emm.2009.41.9.067 · DOI
  54. Walls, 2012, Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid, J. Biol. Chem., 287, 30317, 10.1074/jbc.M112.365890 · DOI · Paper page
  55. Mossmann, 2014, Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation, Cell Metab., 20, 662, 10.1016/j.cmet.2014.07.024 · DOI · Paper page
  56. Yu, 2017, TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype, Neurology, 88, 661, 10.1212/WNL.0000000000003614 · DOI · Paper page
  57. Rapaport, 2001, Structural requirements of Tom40 for assembly into preexisting TOM complexes of mitochondria, Mol. Biol. Cell, 12, 1189, 10.1091/mbc.12.5.1189 · DOI
  58. Sherman, 2006, Effect of mutations in Tom40 on stability of the translocase of the outer mitochondrial membrane (TOM) complex, assembly of Tom40, and import of mitochondrial preproteins, J. Biol. Chem., 281, 22554, 10.1074/jbc.M601630200 · DOI
  59. Gabriel, 2003, Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins, EMBO J., 22, 2380, 10.1093/emboj/cdg229 · DOI
  60. Suzuki, 2004, Membrane-embedded C-terminal segment of rat mitochondrial TOM40 constitutes protein-conducting pore with enriched β-structure, J. Biol. Chem., 279, 50619, 10.1074/jbc.M408604200 · DOI
  61. Kuszak, 2015, Evidence of distinct channel conformations and substrate binding affinities for the mitochondrial outer membrane protein translocase pore Tom40, J. Biol. Chem., 290, 26204, 10.1074/jbc.M115.642173 · DOI
  62. van Waveren, 2008, Transcriptional co-expression and co-regulation of genes coding for components of the oxidative phosphorylation system, BMC Genomics, 9, 1, 10.1186/1471-2164-9-18 · DOI
  63. Humphries, 2005, Dissection of the mitochondrial import and assembly pathway for human Tom40, J. Biol. Chem., 280, 11535, 10.1074/jbc.M413816200 · DOI · Paper page
  64. Wiedemann, 2003, Machinery for protein sorting and assembly in the mitochondrial outer membrane, Nature, 424, 565, 10.1038/nature01753 · DOI · Paper page
  65. Shiota, 2012, The Tom40 assembly process probed using the attachment of different intramitochondrial sorting signals, Mol. Biol. Cell, 23, 3936, 10.1091/mbc.e12-03-0202 · DOI
  66. Voos, 2016, Protein quality control at the mitochondrion, Essays Biochem., 60, 213, 10.1042/EBC20160009 · DOI
  67. Sacht, 1999, ATP-sensitive association of mortalin with the IL-1 receptor type I, Biofactors, 9, 49, 10.1002/biof.5520090107 · DOI
  68. Poindexter, 2002, 3D reconstruction and localization of mortalin by deconvolution microscopy, Microsc. Anal., 21
  69. Kaul, 2005, Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides, J. Biol. Chem., 280, 39373, 10.1074/jbc.M500022200 · DOI
  70. Bender, 2011, Mitochondrial enzymes are protected from stress-induced aggregation by mitochondrial chaperones and the Pim1/LON protease, Mol. Biol. Cell, 22, 541, 10.1091/mbc.e10-08-0718 · DOI
  71. Kiss, 2013, The negative impact of α-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation, FASEB J., 27, 2392, 10.1096/fj.12-220202 · DOI · Paper page
  72. Chinopoulos, 2013, Which way does the citric acid cycle turn during hypoxia? The critical role of α-ketoglutarate dehydrogenase complex, J. Neurosci. Res., 91, 1030, 10.1002/jnr.23196 · DOI · Paper page
  73. Berndt, 2012, Kinetic modeling of the mitochondrial energy metabolism of neuronal cells: the impact of reduced α-ketoglutarate dehydrogenase activities on ATP production and generation of reactive oxygen species, Int. J. Cell Biol., 2012, 11, 10.1155/2012/757594 · DOI
  74. Groen, 1982, Quantification of the contribution of various steps to the control of mitochondrial respiration, J. Biol. Chem., 257, 2754, 10.1016/S0021-9258(19)81026-8 · DOI · Paper page
  75. Ventura, 2002, Control of oxidative phosphorylation by Complex I in rat liver mitochondria: implications for aging, Biochim. Biophys. Acta Bioenerg., 1553, 249, 10.1016/S0005-2728(01)00246-8 · DOI
  76. Telford, 2009, Complex I is rate-limiting for oxygen consumption in the nerve terminal, J. Biol. Chem., 284, 9109, 10.1074/jbc.M809101200 · DOI
  77. Lee, 2012, Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls, J. Psychiatr. Res., 46, 828, 10.1016/j.jpsychires.2012.03.006 · DOI
  78. Chong, 2013, Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer's disease, J. Alzheimers Dis., 34, 399, 10.3233/JAD-121621 · DOI · Paper page
  79. Goh, 2015, TOMM40 alterations in Alzheimer's disease over a 2-year follow-up period, J. Alzheimers Dis., 44, 57, 10.3233/JAD-141590 · DOI
  80. Bender, 2013, TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease, PLoS One, 8, 10.1371/journal.pone.0062277 · DOI · Paper page

Cited by

See all 54

Metadata

Authors
Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A., Roses, A. D., & Gottschalk, W. K.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2017-11
Volume
1863
Issue
11
Pages
2973-2986
ISSN
0925-4439 (ISSN-L)
OpenAlex
W2739591311
Cited by
54
References
33
FWCI
2.14
Type
journal article
Language
en
Update notices
erratum (2018-04-01)
Open access
hybrid
Licence
Funders
National Institutes of Aging (R01 AG040370)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.